MyAverix Finance
HK · Healthcare
Hangzhou Diagens Biotech Co (2526)
Medical Devices
Hangzhou Diagens Biotech Co (2526) is listed on HK in the Healthcare sector. Industry: Medical Devices. As of 2026-05-21, reported market cap is $27.14B, P/E ratio is 18.00, net margin is -40.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2526
Hangzhou Diagens Biotech Co (2526) — FAQ
What is Hangzhou Diagens Biotech Co's market cap?
Hangzhou Diagens Biotech Co (2526) has a reported market cap of $27.14B (data as of 2026-05-21).
What is 2526's P/E ratio?
The price-to-earnings (P/E) ratio for Hangzhou Diagens Biotech Co (2526) is 18.00 (data as of 2026-05-21).
Does Hangzhou Diagens Biotech Co pay a dividend?
Dividend yield is not available in the current snapshot for Hangzhou Diagens Biotech Co (2526). Check the MyAverix Finance app for the latest dividend data.
What sector is Hangzhou Diagens Biotech Co in?
Hangzhou Diagens Biotech Co (2526) is classified in the Healthcare sector (Medical Devices industry).
What exchange is 2526 listed on?
2526 is listed on HK.
What is Hangzhou Diagens Biotech Co's net margin?
Hangzhou Diagens Biotech Co (2526) reports a net margin of -40.8% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.